Jagiellonian University
uj.edu.plTotal trials
155
Active
31
Phase 3
6
Total enrollment
77,675
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 11 of 11 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Nebivolol | — | — | — | — | — | 1 | |
| FLOT + HIPEC + Surgery | — | — | — | — | — | 1 | |
| FLOT + Surgery | — | — | — | — | — | 1 | |
| Ivabradine | — | — | — | — | — | 1 | |
| noradrenaline infusion for management blood pressure | — | — | — | — | — | 1 | |
| standard blood pressure management | — | — | — | — | — | 1 | |
| Chemoimmunotherapy | — | — | — | — | — | 1 | |
| Celiac Plexus Block | — | — | — | — | — | 1 | |
| ESP block | — | — | — | — | — | 1 | |
| Lidacaine | — | — | — | — | — | 1 | |
| Balanced anesthesia with opioids | — | — | — | — | — | 1 |
Next readouts
- 2025-04-30
- 2026-01
- 2026-09-30
- 2026-12-31
- 2027-06-30
- 2027-12-31
- 2029-01-01
Top conditions
- Gastric Cancer5
- Endometriosis4
- Infertility Unexplained4
- Rectal Cancer4
- Goiter3
- Neuroendocrine Tumors3
- Anovulation3
- Pheochromocytoma3
Frequently asked questions about Jagiellonian University
- How many clinical trials does Jagiellonian University have on ClinicalTrials.gov?
- Jagiellonian University is listed as the lead sponsor on 155 clinical trials in ClinicalTrials.gov, 31 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Jagiellonian University's trials are in Phase 3?
- 6 of Jagiellonian University's trials are in Phase 3, spread across 11 active drug programs.
- What therapeutic areas does Jagiellonian University focus on?
- Jagiellonian University's most-studied conditions on ClinicalTrials.gov are Gastric Cancer, Endometriosis, Infertility Unexplained, Rectal Cancer, Goiter.
- When are Jagiellonian University's next clinical trial readouts?
- Jagiellonian University has 7 upcoming primary-completion readouts tracked here; the soonest is “Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)”, expected around 2025-04-30.